MAPT and Alzheimer disease: Furthermore, AHR, the expressed protein, disrupts the GS through its interaction with aryl hydrocarbon receptor nuclear translocator–like protein 1 (BMAL1), thereby impairing the clearance of Aβ and tau proteins and worsening AD pathology (Salminen, 2023).